Authors Title Journal Year Volume Pages 2000 1(1-2) 19-25 2000 … › common › CQ6_PubMed.pdf ·...

Authors Title Journal Year Volume PagesKopp Thyrotoxicosis of other Etiologies 2000DeGroot Diagnosis and Treatment of Graves' 2000Samuels MH, Hyperthyroidism in Aging 2000Burman KD,Wartofsky

Iodine effects on the thyroid gland:biochemical and clinical aspects.

Rev EndocrMetab Disord

2000 1(1-2) 19-25

Pauwels EK, SmitJW, Slats A,

Health effects of therapeutic use of131I in hyperthyroidism.

Q J Nucl Med 2000 44(4) 333-9

Sankar R, Sripathy Radioactive iodine therapy in Graves' Natl Med J India 2000 13(5) 246-51Krassas Thyroid disease and female Fertil Steril 2000 74(6) 1063-70Weetman Graves' disease. N Engl J Med 2000 343(17) 1236-48Zdrojewicz Z,Gawrys G,Tuchendler R,

[Thyrotoxicosis: indications andcontraindications for radioiodinetreatment].

Wiad Lek 2000 53(5-6) 346-54

Rasmussen AK,Nygaard B, Feldt-

(131)I and thyroid-associatedophthalmopathy.

Eur J Endocrinol 2000 143(2) 155-60

Giovanella L, DePalma D, Ceriani L,

[Postoperative hyperthyroidism. Thediagnostic and therapeutic role of

Radiol Med 2000 99(4) 294-7

OrgiazziAnti-TSH receptor antibodies in clinicalpractice.

EndocrinolMetab Clin

2000 29(2) 339-55, vii

Alsanea O, ClarkTreatment of Graves' disease: theadvantages of surgery.

EndocrinolMetab Clin

2000 29(2) 321-37

Palit TK, Miller CC3rd, Miltenburg

The efficacy of thyroidectomy forGraves' disease: A meta-analysis.

J Surg Res 2000 90(2) 161-5

Van Isselt JW, deKlerk JM,

Iodine-131 uptake and turnover ratevary over short intervals in Graves'

Nucl MedCommun

2000 21(7) 609-16

Wichers M, Benz E,Palmedo H,Biersack HJ,

Testicular function after radioiodinetherapy for thyroid carcinoma.

Eur J Nucl Med 2000 27(5) 503-7

Gomi Y, WatanabeM, Yoshimura H,Ishikawa N,

+AFs-The outcome of treatment withadjusted dose of 131I to thyroid weightfor Graves' disease by estimation of

Kaku Igaku 2000 37(2) 109-14

Isotani H, Sanda K,Kameoka K,

McCune-Albright syndrome associatedwith non-autoimmune type of

Horm Res 2000 53(5) 256-9

Pineda P, MichelsenH, Rivera M, Lillo R,Massardo T, Araya

[Treatment of hyperthyroidism withradioiodine: effects of administereddose on complications and thyroid

Rev Med Chil 2000 128(5) 499-507

BucknellFeline hyperthyroidism: spectrum ofclinical presentions and response to

Aust Vet J 2000 78(7) 462-5

Ramirez MJ, PuertoS, Galofre P, ParryEM, Parry JM,

Multicolour FISH detection ofradioactive iodine-induced 17cen-p53chromosomal breakage in buccal cells

Carcinogenesis 2000 21(8) 1581-6

Collins MT, RemaleyAT, Csako G,Pucino F, Skarulis

Increased levothyroxine requirementspresenting as "inappropriate" TSHsecretion syndrome in a patient with

J EndocrinolInvest

2000 23(6) 383-92

Bogazzi F, BartalenaL, Gasperi M,

The various effects of amiodarone onthyroid function.

Thyroid 2001 11(5) 511-9

Mikkelsen KV,Andersen-Ranberg

[Thyroid dysfunction in the elderly]. Ugeskr Laeger 2001 163(20) 2770-3

Nieckarz JA, DanielThe effect of methimazole on thyroiduptake of pertechnetate and radioiodine

Vet RadiolUltrasound

2001 42(5) 448-57

Wesche MF, Tiel-VBuul MM, Lips P,

A randomized trial comparinglevothyroxine with radioactive iodine in

J ClinEndocrinol

2001 86(3) 998-1005

Miller KK, DanielsAssociation between lithium use andthyrotoxicosis caused by silent

Clin Endocrinol(Oxf)

2001 55(4) 501-8

Borras-Perez MV,Moreno-Perez D,Zuasnabar-Cotro A,

Neonatal hyperthyroidism in infants ofmothers previously thyroidectomizeddue to Graves' disease.

J PediatrEndocrinolMetab

2001 14(8) 1169-72

Faber J, Wiinberg N,Schifter S, Mehlsen

Haemodynamic changes followingtreatment of subclinical and overt


Tanwani LK, LohanoV, Ewart R,

Myasthenia gravis in conjunction withGraves' disease: a diagnostic challenge.

Endocr Pract 2001 7(4) 275-8

Sekhar RV,Vassilopoulou-Sellin

Interplay of pregnancy, lactation, andhyperthyroidism leading to severe

Endocr Pract 2001 7(4) 262-6

Suzuki K, NakagawaO, Aizawa

A case of pulmonary metastatic thyroidcancer complicated with Graves'

Endocr J 2001 48(2) 175-9

Iitaka M, KakinumaS, Yamanaka K,Fujimaki S, Oosuga

Induction of autoimmune hypothyroidismand subsequent hyperthyroidism byTSH receptor antibodies following

Endocr J 2001 48(2) 139-42

Clerc J, Kahn E,Fragu

SIMS evidence that carbimazoleenhances spatial heterogeneity ofthyroid iodine storage and targeting in a

Cell Mol Biol(Noisy-le-grand)

2001 47(3) 519-27

Sabri O, Zimny M,Schreckenberger M,Reinartz P, NowakB, Ostwald E,

[Characterization of therapy failures inradioiodine therapy of Graves' diseasewithout simultaneous antithyroidagents].

Nuklearmedizin 2001 40(1) 1-6

Bricker LA, Such F,Loehrke ME,

Intractable diarrhea in hyperthyroidism:management with beta-adrenergic

Endocr Pract 2001 7(1) 28-31

Basu S, Nair N,Aravind

Unilateral proptosis with thyrotoxicosisresulting from solitary retroorbital softtissue metastasis from follicular

Clin Nucl Med 2001 26(2) 136-8

Bryer-Ash M, LodhiW, Robbins K,

Early thyrotoxic thyroiditis afterradiotherapy for tonsillar carcinoma.

ArchOtolaryngol

2001 127(2) 209-11

Baskin HJ, CobinRH, Duick DS,Gharib H, Guttler

American Association of ClinicalEndocrinologists medical guidelines forclinical practice for the evaluation and

Endocr Pract 2002 8(6) 457-69

Bhansali SK,Chandalia

Thyrotoxicosis--surgical management inthe era of evidence-based medicine:

Asian J Surg 2002 25(4) 291-9

Thompson Surgical management in Graves' Panminerva Med 2002 44(4) 287-93Reiners C,Schneider

Radioiodine therapy of thyroidautonomy.

Eur J Nucl MedMol Imaging

2002 29 Supp S471-8

BettendorfThyroid disorders in children from birthto adolescence.


2002 29 Supp S439-46

Fisher Management of thyrotoxicosis. South Med J 2002 95(5) 493-505Papi G, Carapezzi [The management of thyrotoxicosis: a Minerva 2002 27(2) 119-26Seshadri P, FrankKD, Iqbal

Thyrotoxic hypokalemic periodicparalysis in a Native American patient:

Endocr Pract 2002 8(5) 362-3

Sussman SK, KhoSA, Cersosimo E,

Coexistence of malignant struma ovariiand Graves' disease.

Endocr Pract 2002 8(5) 378-80

Jurgilewicz DH,Rogowski F,Lebkowska U, Citko

E-selectin, L-selectin, ICAM-1 and IL-6concentrations changes in the serum ofpatients with hyperthyroidism in the

Nucl Med RevCent East Eur

2002 5(1) 39-42

Calderwood C,Williams H, Campbell

Cordocentesis to predict fetal outcomeafter administration of radio-active

J ObstetGynaecol

2002 22(2) 217-8

Krassas GE,Pontikides N,

A prospective controlled study of theimpact of hyperthyroidism on

J ClinEndocrinol

2002 87(8) 3667-71

Hsieh CJ, Wang PW,Wang ST, Liu RT,Tung SC, Chien WY,

Serum leptin concentrations of patientswith sequential thyroid functionchanges.


2002 57(1) 29-34

Hyer S, Vini L,O'Connell M, Pratt

Testicular dose and fertility in menfollowing I(131) therapy for thyroid


2002 56(6) 755-8

Lissak B, TazartesM, Heron E,

[Thyroid orbital pathologies inophthalmological settings].

Presse Med 2002 31(2) 64-8

KrassasOphthalmic complications in juvenileGraves' Disease - clinic and therapeutic

PediatrEndocrinol Rev

2003 1 Suppl 223-9; disc

Rajeswaran C, Management of amiodarone-induced Swiss Med Wkly 2003 133(43-579-85

Bianconcini M,Giannini

[Amiodarone-induced thyrotoxicosis:case report and review of the

Ital Heart JSuppl

2003 4(8) 682-7

Cooper Hyperthyroidism. Lancet 2003 362(938459-68Intenzo CM, dePappAE, Jabbour S,

Scintigraphic manifestations ofthyrotoxicosis.

Radiographics 2003 23(4) 857-69

Streetman DD, Diagnosis and treatment of Graves Ann 2003 37(7-8) 1100-9Krassas GE, Perros Thyroid disease and male reproductive J Endocrinol 2003 26(4) 372-80

Orgiazzi J, MadecAM, Ducottet

The role of stimulating, function-blocking and growth-blocking anti-TSHreceptor antibodies (TRAbs) in GD,

Ann Endocrinol(Paris)

2003 64(1) 31-6

Schumm-DraegerPM, Muller

[Therapy of hyperthyroidism].Dtsch MedWochenschr

2003 128(10) 500-2

Emerson CH, TorresRecombinant human thyroid-stimulatinghormone: pharmacology, clinical

BioDrugs 2003 17(1) 19-38

Bonnema SJ,Bennedbaek FN,Gram J, Veje A,

Resumption of methimazole after 131Itherapy of hyperthyroid diseases: effecton thyroid function and volume


Bogazzi F, MartinoE, Dell'Unto E,Brogioni S, Cosci C,Aghini-Lombardi F,Ceccarelli C,

Thyroid color flow doppler sonographyand radioiodine uptake in 55consecutive patients with amiodarone-induced thyrotoxicosis.

J EndocrinolInvest

2003 26(7) 635-40

Gomez-Arnaiz N,Andia E, Guma A,Abos R, Soler J,

Ultrasonographic thyroid volume as areliable prognostic index of radioiodine-131 treatment outcome in Graves'

Horm MetabRes

2003 35(8) 492-7

Ivovic M,Radiojkovic B,Penezic Z, Stojkovic

[Agranulocytosis and acute coronarysyndrome in apathetic hyperthyroidism].

Srp Arh CelokLek

2003 131(5-6249-53

Schicha [How does it function? Radioiodine MMW Fortschr 2003 145(42) 71-2Fang L, Tan T, PanM, Wu

[Comparison of the radioiodine thyroiduptake of diagnostic dose and

Sichuan Da XueXue Bao Yi Xue

2003 34(2) 281-2, 346

Brunova J, Bruna J,Joubert G, Koning

Weight gain in patients after therapy forhyperthyroidism.

S Afr Med J 2003 93(7) 529-31

Fujii S, Miwa U, SetaT, Ohoka T,

Subacute thyroiditis with highly positivethyrotropin receptor antibodies and high

Intern Med 2003 42(8) 704-9

Tanwani LK,Chudgar D,Murphree SS, Eblen

A case of gonadal dysgenesis, breastdevelopment, Graves' disease, and lowbone mass.

Endocr Pract 2003 9(3) 220-4

Lore F, Polito E,Cerase A, Bracco S,Loffredo A, Pichierri

Carotid cavernous fistula in a patientwith Graves' ophthalmopathy.

J ClinEndocrinolMetab

2003 88(8) 3487-90

Corssmit EP,Wiersinga

[Subclinical hyperthyroidism: notnecessarily a thyroid disorder].

Ned TijdschrGeneeskd

2003 147(24) 1153-5

Huszno B,Hubalewska-Hola A,Baldys-Waligorska

The impact of iodine prophylaxis onthyroid 131-iodine uptake in the regionof Krakow, Poland.

J EndocrinolInvest

2003 26(2 Su 7-10

Franklyn Thyrotoxicosis. Clin Med (Lond) 2003 3(1) 11-5Andrade VA, GrossJL, Maia

[Radioactive iodine therapy in Graves'hyperthyroidism].

Arq BrasEndocrinol

2004 48(1) 159-65

Ralph Finding and treating the cause of JAAPA 2004 17(2) 20, 23-6, 2

Dralle H, Sekulla[Morbidity after subtotal and totalthyroidectomy in patients with Graves'disease: the basis for decision-making

Z Arztl FortbildQualitatssich

2004 98 Supp 45-53

Smith JR, OatesRadionuclide imaging of the thyroidgland: patterns, pearls, and pitfalls.

Clin Nucl Med 2004 29(3) 181-93

Krassas GE,Pontikides

Male reproductive function in relationwith thyroid alterations.

Best Pract ResClin Endocrinol

2004 18(2) 183-95

Bednarek-Tupikowska G, Filus

[Amiodarone and the thyroid gland].Postepy HigMed Dosw

2004 58 216-25

KrassasTreatment of juvenile Graves' diseaseand its ophthalmic complication: the


Topliss DJ, Eastman5: Diagnosis and management ofhyperthyroidism and hypothyroidism.

Med J Aust 2004 180(4) 186-93

Rogowski F,Parfienczyk A,Sopotyk A,Budlewski T,

The value of estimating serumaproptotic marker concentrations inmonitoring and prognosis of 131I--therapy in Graves' disease. Preliminary


2004 7(2) 117-22

Erdogan MF, KucukNO, Anil C, Aras S,

Effect of radioiodine therapy on thyroidnodule size and function in patients with

Nucl MedCommun

2004 25(11) 1083-7

Traino AC, DiMartino F, Lazzeri

A dosimetric approach to patient-specific radioiodine treatment ofGraves' disease with incorporation of

Med Phys 2004 31(7) 2121-7

Takamura N,Nakamura Y, IshigakiK, Ishigaki J, Mine

Thyroid blockade during a radiationemergency in iodine-rich areas: effectof a stable-iodine dosage.

J Radiat Res 2004 45(2) 201-4

Kita T, Yokoyama K,Kinuya S, Taki J,

Single dose planning for radioiodine-131therapy of Graves' disease.

Ann Nucl Med 2004 18(2) 151-5

Yamashita Y,Yamane K, Tamura

Onset age is associated with outcomeof radioiodine therapy in Graves'

Endocr J 2004 51(2) 127-32

Miyazaki S, KamiishiT, Hosokawa N,Komura M, Konagai

Reversible left ventricular dysfunction"takotsubo" cardiomyopathy associatedwith hyperthyroidism.

Jpn Heart J 2004 45(5) 889-94

Eckstein AK, PlichtM, Lax H, Hirche H,Quadbeck B, Mann

Clinical results of anti-inflammatorytherapy in Graves' ophthalmopathy andassociation with thyroidal


2004 61(5) 612-8

Larisch R, Kley K,Nikolaus S, Sitte W,Franz M, Hautzel H,

Depression and anxiety in differentthyroid function states.

Horm MetabRes

2004 36(9) 650-3

Bartalena L,Wiersinga WM,Tanda ML, Bogazzi

Diagnosis and management ofamiodarone-induced thyrotoxicosis inEurope: results of an international


2004 61(4) 494-502

Read CH Jr, TanseyMJ, Menda

A 36-year retrospective analysis of theefficacy and safety of radioactive iodine

J ClinEndocrinol

2004 89(9) 4229-33

He JF, Wu ZY, YangHS, Yan JH, Mao

[Clinical analysis of 339 cases ofthyroid-associated ophthalmopathy].

Zhonghua YanKe Za Zhi

2004 40(6) 368-72

Chung YH, Ou HY,Wu

Development of hyperthyroidismfollowing primary hypothyroidism: a case

Kaohsiung JMed Sci

2004 20(4) 188-91

Hermida JS, JarryG, Tcheng E,Moullart V, Arlot S,

[Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].

Arch Mal CoeurVaiss

2004 97(3) 207-13

Ciccarelli A, Valdes-Socin H, Parma J,Khoo SK,

Thyrotoxic adenoma followed byatypical hyperthyroidism due to strumaovarii: clinical and genetic studies.


Rink T, Bormuth FJ,Braun S, Zimny M,

[Concept and validation of a simplemodel of the intrathyroidal iodine


Mazeto GM, OliveiraML, Padovani CR,Montenegro MR,

Thyroid cell proliferation in Graves'disease. Use of MIB-1 monoclonalantibody.

Acta Cytol 2004 48(1) 57-63

Kociura-Sawicka A,Rogowski F,Abderlazek S,

[Subclinical hyperthyrodism, diagnosisand radioiodine therapy].

Przegl Lek 2005 62(9) 903-7

Weissel [Thyroid dysfunction in aged persons].Wien MedWochenschr

2005 155(19-458-62

Krassas GE,Pontikides

Gonadal effect of radiation from 131I inmale patients with thyroid carcinoma.

Arch Androl 2005 51(3) 171-5

AmerAdvances in assessment, diagnosis, andtreatment of hyperthyroidism in

J Pediatr Nurs 2005 20(2) 119-26

LazarusThyroid disorders associated withpregnancy: etiology, diagnosis, and

Treat Endocrinol 2005 4(1) 31-41

Perros P, Kendall-Taylor P, Neoh C,Frewin S, Dickinson

A prospective study of the effects ofradioiodine therapy for hyperthyroidismin patients with minimally active graves'


2005 90(9) 5321-3

Azizi F, Ataie L,Hedayati M, Mehrabi

Effect of long-term continuousmethimazole treatment of

Eur J Endocrinol 2005 152(5) 695-701

Minelli R, Valli MA,Di Secli C, Finardi L,Chiodera P, BertoniR, Ferrari C, Barilli

Is steroid therapy needed in thetreatment of destructive thyrotoxicosisinduced by alpha-interferon in chronichepatitis C?

Horm Res 2005 63(4) 194-9

MohammadiRadiation exposure rate from 131I-treated hyperthyroid patients--a

Health Phys 2005 88(5) 486-90

Aldighieri FC,Duarte PS, Alonso

[Reference values for thyroid 24 hours123I uptake].

Arq BrasEndocrinol

2005 49(3) 425-32

Paul AK, Al-NahhasA, Ansari SM, Islam

Skin eruptions following treatment withIodine-131 for hyperthyroidism: a rareand un-reported early/intermediate side


2005 8(2) 125-7

Kubota S, Ohye H,Sasaki I, NishiharaE, Kudo T, Fukata S,Amino N, Kuma K,

Successful use of iodine andlevothyroxine to treat Graves' diseasein a pregnant patient with allergy toantithyroid drugs and high thyrotropin-

Thyroid 2005 15(12) 1373-6

Tajiri[Radioiodine treatment in patients withGraves' disease at outpatient clinic:special reference to safety and short-

Kaku Igaku 2005 42(2) 115-22

Heymann RS, BrentGA, Hershman

Anaplastic thyroid carcinoma withthyrotoxicosis and hypoparathyroidism.

Endocr Pract 2005 11(4) 281-4

Franklyn JA,Sheppard MC,

Thyroid function and mortality inpatients treated for hyperthyroidism.

JAMA 2005 294(1) 71-80

Jensen BE,Bonnema SJ,

Glucocorticoids do not influence theeffect of radioiodine therapy in Graves'


Rozendaal[Hyperthyroidism in the elderly:aspecific signs may cause a delay in

TijdschrGerontol Geriatr

2005 36(2) 77-80

Alzahrani AS,Aldasouqi S, Salam

Autoimmune thyroid disease withfluctuating thyroid function.

PLoS Med 2005 2(5) e89

Grosso M, Traino A,Boni G, Banti E,Della Porta M,Manca G, VolterraniD, Chiacchio S,

Comparison of different thyroidcommitted doses in radioiodine therapyfor Graves' hyperthyroidism.

Cancer BiotherRadiopharm

2005 20(2) 218-23

Momotani[Current problems in the treatment ofGraves' disease in pregnancy and in

Nihon Rinsho 2006 64(12) 2297-302

Konishi[Radioiodine treatment of Graves'disease --for its wider indication and

Nihon Rinsho 2006 64(12) 2257-61

Mezosi [Hyperthyroidism]. Orv Hetil 2006 147(28) 1309-14Maruna [Gynecological aspects of thyroid Ceska Gynekol 2006 71(4) 332-8Bach-Huynh TG, Thyroid medications during pregnancy. Ther Drug Monit 2006 28(3) 431-41

KungClinical review: Thyrotoxic periodicparalysis: a diagnostic challenge.

J ClinEndocrinol

2006 91(7) 2490-5

PetersonRadioiodine treatment ofhyperthyroidism.

Clin Tech SmallAnim Pract

2006 21(1) 34-9

Azizi The safety and efficacy of antithyroid Expert Opin 2006 5(1) 107-16Canzi C, Zito F,Voltini F, Reschini E,

Verification of the agreement of twodosimetric methods with radioiodine

Med Phys 2006 33(8) 2860-7

Nielsen VE,Bonnema SJ,Hegedus

Transient goiter enlargement afteradministration of 0.3 mg of recombinanthuman thyrotropin in patients with


2006 91(4) 1317-22

Prinsen AK, JansenJ, Bakker WH,

[Radioiodine therapy for women withGraves' disease and the risk of foetal

Ned TijdschrGeneeskd

2006 150(52) 2845-8

Ceccarelli C, CanaleD, Battisti P,Caglieresi C,Moschini C, Fiore E,

Testicular function after 131I therapyfor hyperthyroidism.


2006 65(4) 446-52

Tarantini B, CiuoliC, Di Cairano G,Guarino E,Mazzucato P,

Effectiveness of radioiodine (131-I) asdefinitive therapy in patients withautoimmune and non-autoimmunehyperthyroidism.

J EndocrinolInvest

2006 29(7) 594-8

Laurberg P,Jorgensen T, PerrildH, Ovesen L,Knudsen N,

The Danish investigation on iodineintake and thyroid disease, DanThyr:status and perspectives.


Maeda S, Uga T,Hayashida N,

Video-assisted subtotal or near-totalthyroidectomy for Graves' disease.

Br J Surg 2006 93(1) 61-6

Wexler JA,Sharretts

Thyroid and bone.EndocrinolMetab Clin

2007 36(3) 673-705, v

Chan GW, MandelTherapy insight: management of Graves'disease during pregnancy.

Nat Clin PractEndocrinol

2007 3(6) 470-8

Volzke H, SchwahnC, Wallaschofski H,

Review: The association of thyroiddysfunction with all-cause and

J ClinEndocrinol

2007 92(7) 2421-9

Zen XX, Yuan Y, LiuY, Wu TX, Han

Chinese herbal medicines forhyperthyroidism.

CochraneDatabase Syst

2007 (2) CD005450

Berent AC, DrobatzKJ, Ziemer L,

Liver function in cats withhyperthyroidism before and after 131I

J Vet InternMed

2007 21(6) 1217-23

Dunkelmann S,Kuenstner H, NabaviE, Rohde B, Groth

Change in the intrathyroidal kinetics ofradioiodine under continued anddiscontinued antithyroid medication in


2007 34(2) 228-36

Alnaqdy A, Al-Maskari

Levels of cytokines and thyroidautoantibodies in Omani patients with

Br J Biomed Sci 2007 64(4) 164-7

Kabadi UM,Premachandra

Serum thyrotropin in Graves' disease: amore reliable index of circulatingthyroid-stimulating immunoglobulin level

Endocr Pract 2007 13(6) 615-9

Sopena Bert E,Valenti Moreno V,

[Postpartum thyroiditis with unusualevolution].

An Med Interna 2007 24(6) 305-6

Bogazzi F, BartalenaL, Dell'Unto E,Tomisti L, Rossi G,Pepe P, Tanda ML,Grasso L, Macchia

Proportion of type 1 and type 2amiodarone-induced thyrotoxicosis haschanged over a 27-year period in Italy.


2007 67(4) 533-7

Hasegawa T, ArakiA, Tamura Y,Sugawara T, Iwata

[A case of Plummer disease thatappeared in older old age after 10-yearcourse of subclinical hyperthyroidism].

Nihon RonenIgakkai Zasshi

2007 44(2) 251-5

Niessen SJ, VoyceMJ, de Villiers L,Hargreaves J,

Generalised lymphadenomegalyassociated with methimazole treatmentin a hyperthyroid cat.

J Small AnimPract

2007 48(3) 165-8

Subramanian V,Yaturu

Symptomatic ascites in a patient withhypothyroidism of short duration.

Am J Med Sci 2007 333(1) 48-52

Osman F, FranklynJA, Holder RL,

Cardiovascular manifestations ofhyperthyroidism before and after

J Am CollCardiol

2007 49(1) 71-81

Piga M, Serra A, BoiF, Tanda ML,

Amiodarone-induced thyrotoxicosis. Areview.

MinervaEndocrinol

2008 33(3) 213-28

Ceccarelli C, Canale Radioactive iodine (131I) effects on Curr Opin Urol 2008 18(6) 598-601Brent Clinical practice. Graves' disease. N Engl J Med 2008 358(24) 2594-605Mai VQ, Glister BC,Clyde PW, Shakir

Palpation thyroiditis causing new-onsetatrial fibrillation.

Thyroid 2008 18(5) 571-3

Muller AF, BerghoutA, Wiersinga WM,

Thyroid function disorders--Guidelinesof the Netherlands Association of

Neth J Med 2008 66(3) 134-42

Sawka AM, Lea J,Alshehri B, StrausS, Tsang RW,Brierley JD,

A systematic review of the gonadaleffects of therapeutic radioactive iodinein male thyroid cancer survivors.


2008 68(4) 610-7

Greenlund LJ, NairKS, Brennan

Changes in body composition in womenfollowing treatment of overt and

Endocr Pract 2008 14(8) 973-8

Ogiso S, Inamoto S,Hata H, Yamaguchi

Successful treatment of gastricperforation with thyrotoxic crisis.

Am J EmergMed

2008 26(9) 1065.e3-4

Kiratli PO, GedikProblems and pitfalls in thyroid uptakemeasurements with iodine-131.

Hell J Nucl Med 2008 11(3) 187-8

Sebastian-Ochoa A,Quesada-CharnecoM, Fernandez-Garcia D, Reyes-

Dramatic response to cholestyramine ina patient with Graves' disease resistantto conventional therapy.

Thyroid 2008 18(10) 1115-7

Yandell SD, HarveyWC, Fernandes NJ,

Radioiodine studies, low serumthyrotropin, and the influence of statin

Thyroid 2008 18(10) 1039-42

Kobe C, Weber I,Eschner W,Sudbrock F,

Graves' disease and radioiodine therapy.Is success of ablation dependent on thechoice of thyreostatic medication?


Michalaki M,Kyriazopoulou V,Paraskevopoulou P,

The odyssey of nontoxic nodular goiter(NTNG) in Greece under suppressiontherapy, and after improvement of

Thyroid 2008 18(6) 641-5

Perry RJ, Ainine A,Butler S, Donaldson

Hypoechoic thyroid nodules onultrasound 4 years after prenatal

Acta Paediatr 2008 97(4) 509-12

Ruchala M,Szczepanek E,Skiba A,

Graves' hyperthyroidism followingprimary hypothyroidism due toHashimoto's thyroiditis in a case of

NeuroEndocrinol Lett

2008 29(1) 55-8

Kobe C, Eschner W,Sudbrock F, WeberI, Marx K, Dietlein

Graves' disease and radioiodine therapy.Is success of ablation dependent on theachieved dose above 200 Gy?


Baldys-WaligorskaA, Golkowski F,Sokolowski G,Buziak-Bereza M,

[A case of Graves-Basedow diseasewith orbitopathy and papillary thyroidcancer].

Endokrynol Pol 2008 59(6) 516-20

Berg G, JacobssonL, Nystrom E,Gleisner KS,

Consequences of inadvertentradioiodine treatment of Graves' diseaseand thyroid cancer in undiagnosed

Acta Oncol 2008 47(1) 145-9

Eskes SA, Wiersinga Amiodarone and thyroid.Best Pract ResClin Endocrinol

2009 23(6) 735-51

Lazarus Lithium and thyroid.Best Pract ResClin Endocrinol

2009 23(6) 723-33

Drugs for thyroid disorders. Treat Guidel 2009 7(84) 57-64; quiz Karger S, Fuhrer- [Thyroid diseases and pregnancy]. Med Klin 2009 104(6) 450-6Fumarola A,Calvanese A, Di

[Antithyroid drugs therapy]. Clin Ter 2009 160(1) 47-53

Filesi M, ColandreaM, Montesano T,

Thyroid stunning in clinical practice: is ita real problem?

MinervaEndocrinol

2009 34(1) 29-36

Spiezia S,Garberoglio R,Milone F, RamundoV, Caiazzo C,Assanti AP,

Thyroid nodules and related symptomsare stably controlled two years afterradiofrequency thermal ablation.

Thyroid 2009 19(3) 219-25

Romao R, Rubio IG,Tomimori EK,Camargo RY, KnobelM, Medeiros-Neto

High prevalence of side effects afterrecombinant human thyrotropin-stimulated radioiodine treatment with 30mCi in patients with multinodular goiter

Thyroid 2009 19(9) 945-51

Czarnywojtek A,Czepczynski R,Ruchala M, WaskoR, Zgorzalewicz-Stachowiak M,

Radioiodine therapy in patients withamiodarone-induced thyrotoxicosis(AIT).


2009 30(2) 209-14

Nebesio TD, EugsterUnusual thyroid constellation in Downsyndrome: congenital hypothyroidism,Graves' disease, and hemiagenesis in

J PediatrEndocrinolMetab

2009 22(3) 263-8

Regalbuto C,Marturano I,

Radiometabolic treatment ofhyperthyroidism with a calculated dose

J EndocrinolInvest

2009 32(2) 134-8

Vita R, Lapa D, VitaG, Trimarchi F,

A patient with stress-related onset andexacerbations of Graves disease.

Nat Clin PractEndocrinol

2009 5(1) 55-61

Rivkees Pediatric Graves' disease: controversies Horm Res 2010 74(5) 305-11Earl R, CrowtherCA, Middleton

Interventions for preventing and treatinghyperthyroidism in pregnancy.


2010 (9) CD008633

Padmanabhan Amiodarone and thyroid dysfunction. South Med J 2010 103(9) 922-30Fitzpatrick DL,Russell

Diagnosis and management of thyroiddisease in pregnancy.

Obstet GynecolClin North Am

2010 37(2) 173-93

Stan MN, BahnRisk factors for development ordeterioration of Graves'

Thyroid 2010 20(7) 777-83

Misaki[Therapeutic guidelines:progress indiagnosis and treatment. 2. Internal

Nihon NaikaGakkai Zasshi

2010 99(4) 741-6

Espiritu RP, Dean Parathyroidectomy-induced thyroiditis. Endocr Pract 2010 16(4) 656-9

Tran P, Desimone S,Barrett M, Bachrach

I-131 treatment of graves' disease in anunsuspected first trimester pregnancy;the potential for adverse effects on thefetus and a review of the current

Int J PediatrEndocrinol

2010 2010 858359

FranklynWhat is the role of radioiodine uptakemeasurement and thyroid scintigraphy


2010 72(1) 11-2

Jukic T, Stanicic J,Petric V, Kusic

[Radioiodine versus surgery in thetreatment of Graves' hyperthyroidism].

Lijec Vjesn 2010 132(11-355-60

Minder EI,Haldemann AR,

Exacerbation of erythropoieticprotoporphyria by hyperthyroidism.

J Inherit MetabDis

2010 33 Supp S465-9

Sakurai K, FukazawaH, Arihara Z,

Sunitinib-induced thyrotoxicosisfollowed by persistent hypothyroidism

Tohoku J ExpMed

2010 222(1) 39-44

Al-Sharif AA,Abujbara MA,

Contribution of radioiodine uptakemeasurement and thyroid scintigraphy

Hell J Nucl Med 2010 13(2) 132-7

Ariza MA, LokenWM, Pearce EN,Safer

Male sex, African American race orethnicity, and triiodothyronine levels atdiagnosis predict weight gain after

Endocr Pract 2010 16(4) 609-16

Bertalan R, Sallai A,Solyom J, Lotz G,Szabo I, Kovacs B,

Hyperthyroidism caused by a germlineactivating mutation of the thyrotropinreceptor gene: difficulties in diagnosis

Thyroid 2010 20(3) 327-32

van Hoek IM,Vandermeulen E,Peremans K,

Thyroid stimulation with recombinanthuman thyrotropin in healthy cats, catswith non-thyroidal illness and in cats

J Feline MedSurg

2010 12(2) 117-21

Okosieme OE, ChanD, Price SA,

The utility of radioiodine uptake andthyroid scintigraphy in the diagnosis and


2010 72(1) 122-7

Orgiazzi[The treatment of Graves' disease:current views and controversies].

Presse Med 2011 40(12 P 1155-62

Faggiano A, DelPrete M, MarcielloF, Marotta V,

Thyroid diseases in elderly.MinervaEndocrinol

2011 36(3) 211-31

Hamnvik OP, LarsenPR, Marqusee

Thyroid dysfunction from antineoplasticagents.

J Natl CancerInst

2011 103(21) 1572-87

Gurgul E, SowinskiPrimary hyperthyroidism--diagnosis andtreatment. Indications and


2011 14(1) 29-32

Bahn RS, Burch HB,Cooper DS, GarberJR, Greenlee MC,Klein I, Laurberg P,McDougall IR,

Hyperthyroidism and other causes ofthyrotoxicosis: management guidelinesof the American Thyroid Associationand American Association of ClinicalEndocrinologists.

Endocr Pract 2011 17(3) 456-520

Bahn Chair RS,Burch HB, CooperDS, Garber JR,Greenlee MC, KleinI, Laurberg P,McDougall IR,

Hyperthyroidism and other causes ofthyrotoxicosis: management guidelinesof the American Thyroid Associationand American Association of ClinicalEndocrinologists.

Thyroid 2011 21(6) 593-646

Ilyes [Current questions of thyroid diseases Orv Hetil 2011 152(16) 617-27Sisson JC, FreitasJ, McDougall IR,Dauer LT, HurleyJR, Brierley JD,Edinboro CH,

Radiation safety in the treatment ofpatients with thyroid diseases byradioiodine 131I : practicerecommendations of the AmericanThyroid Association.

Thyroid 2011 21(4) 335-46

Azizi F, Amouzegar Management of hyperthyroidism during Eur J Endocrinol 2011 164(6) 871-6Ross Radioiodine therapy for hyperthyroidism. N Engl J Med 2011 364(6) 542-50Rogowski F,Abdelrazek S,Szumowski P,

The influence of non-radioactive iodine(127I) on the outcome of radioiodine(131I) therapy in patients with Graves'


2011 14(1) 9-15

Bonnema SJ, GrupeP, Boel-Jorgensen

A randomized trial evaluating a block-replacement regimen during radioiodine

Eur J ClinInvest

2011 41(7) 693-702

Jain V, ChenHyperandrogenism in a set of tripletswith modification of clinical course by

J PediatrEndocrinol

2011 24(11-11055-7

Pramyothin P,Leung AM, Pearce

Clinical problem-solving. A hiddensolution.

N Engl J Med 2011 365(22) 2123-7

Nakano Y, Kurihara Graves' disease following subacute Tohoku J Exp 2011 225(4) 301-9

Nakatake N, FukataS, Tajiri

Prediction of post-treatmenthypothyroidism using changes in thyroidvolume after radioactive iodine therapy

Int J PediatrEndocrinol

2011 2011 14

Noh KW, Seon CS,Choi JW, Cho YB,

Thyroid storm and reversible thyrotoxiccardiomyopathy after ingestion of

Thyroid 2011 21(6) 679-82

Stathatos N, Gaz R,Ross DS, Daniels

High radioactive iodine uptake despite afully suppressed TSH in a patient with

J ClinEndocrinol

2011 96(3) 589

Liu JM, Gu LQ,Zhao L, Tang ZY,Sun LH, Hong J,Wang WQ, Luo BY,Zhao YJ, Xu MY,

Two unusual cases of intractablehyperthyroidism responsive tooctreotide: Munchausen syndrome ornot?

Clin Chim Acta 2011 412(11-1155-60

Kaminski G,Michalkiewicz D,Makowski K,Podgajny Z, Szalus

Prospective echocardiographicevaluation of patients with endogenoussubclinical hyperthyroidism and afterrestoring euthyroidism.


2011 74(4) 501-7

Hamada N,Momotani N,Ishikawa N,

Persistent high TRAb values duringpregnancy predict increased risk ofneonatal hyperthyroidism following

Endocr J 2011 58(1) 55-8

Hen K,Czarnywojtek A,Stangierski A,Warmuz-

[Effect of amiodarone on the thyroidfunction and safety of the therapy--what's new].

Przegl Lek 2012 69(10) 1135-9

Dilas LT, Bajkin I,Icin T, Paro JN,

[Iodine and thyroid gland with or withoutnuclear catastrophe].

Med Pregl 2012 65(11-1489-95

Misaki[Indication and contraindication ofradioiodine therapy for Graves' disease].

Nihon Rinsho 2012 70(11) 1922-6

Gessl A, Lemmens-Gruber R, Kautzky-

Thyroid disorders.Handb ExpPharmacol

2012 (214) 361-86

Leung AM,Braverman

Iodine-induced thyroid dysfunction.Curr OpinEndocrinol

2012 19(5) 414-9

Hegedus L,Bonnema SJ, Smith

Treating the thyroid in the presence ofGraves' ophthalmopathy.

Best Pract ResClin Endocrinol

2012 26(3) 313-24

Trapp CM, ElderRW, Gerken AT,Sopher AB, Lerner

Pediatric pulmonary arterialhypertension and hyperthyroidism: apotentially fatal combination.


2012 97(7) 2217-22

Lazarus Pre-conception counselling in graves' Eur Thyroid J 2012 1(1) 24-9Seigel SC, Hodak Thyrotoxicosis. Med Clin North 2012 96(2) 175-201Franklyn JA, Thyrotoxicosis. Lancet 2012 379(9821155-66Azizi F, Yousefi V,Bahrainian A,Sheikholeslami F,

Long-term continuous methimazole orradioiodine treatment forhyperthyroidism.

Arch Iran Med 2012 15(8) 477-84

Adedapo KS, FadijiIO, Orunmuyi AT,

Radioactive iodine ablation therapy: aviable option in the management of

Afr J Med MedSci

2012 41 Supp193-6

Quidute AR, FreitasEV, Lima TG,

Achalasia and thyroid disease: possibleautoimmune connection?

Arq BrasEndocrinol

2012 56(9) 677-82

Zhao X, Chen L, LiL, Wang Y, Wang Y,Zhou L, Zeng F, Li

Peak systolic velocity of superiorthyroid artery for the differentialdiagnosis of thyrotoxicosis.

PLoS One 2012 7(11) e50051

Schaarschmidt J,Paschke S, OzerdenM, Jaschke H, HuthS, Eszlinger M,

Late manifestation of subclinicalhyperthyroidism after goitrogenesis inan index patient with a N670S TSHreceptor germline mutation

Horm MetabRes

2012 44(13) 962-5

Moura-Neto A,Mosci C, SantosAO, Amorim BJ, deLima MC,

Predictive factors of failure in a fixed 15mCi 131I-iodide therapy for Graves'disease.

Clin Nucl Med 2012 37(6) 550-4

Chen L, Zhao X, LiuH, Wang Y, Li L, LuB, Li Y, Hu

Mean peak systolic velocity of thesuperior thyroid artery is correlatedwith radioactive iodine uptake in

J Int Med Res 2012 40(2) 640-7

Carluccio AL,Sundaram NK,

Apathetic thyrotoxicosis secondary toatypical subacute thyroiditis.

Endocr Pract 2012 18(5) e127-9

Branter E, DrescherN, Padilla M,

Antioxidant status in hyperthyroid catsbefore and after radioiodine treatment.

J Vet InternMed

2012 26(3) 582-8

Sawicka N, SowinskiCorrelation between thyroid volume andhumoral thyroid autoimmunity after

Endokrynol Pol 2012 63(1) 10-3

Osaki Y, Sakurai K,Arihara Z, Hata M,

Prediction of late (24-hour) radioactiveiodine uptake using early (3-hour)

Endocr J 2012 59(2) 173-7

Park J, Kim JG, Asymmetric chorea as presenting Neurol Sci 2012 33(2) 343-5Peacey SR, KumarS, Wright D, King

The follow-up of radioiodine-treatedhyperthyroid patients: should thyroid

J EndocrinolInvest

2012 35(1) 82-6

Naji P, Kumar G,Dewani S, DiedrichWA, Gupta

Graves' disease causing pancytopeniaand autoimmune hemolytic anemia atdifferent time intervals: a case report

Case Rep Med 2013 2013 194542

Batra Fetal and neonatal thyrotoxicosis.Indian JEndocrinol

2013 17(Supp S50-4

Earl R, CrowtherCA, Middleton

Interventions for hyperthyroidism pre-pregnancy and during pregnancy.


2013 (11) CD008633

Galofre JC, Chacon Targeting thyroid diseases with TSH Endocrinol Nutr 2013 60(10) 590-8

Leger J, CarelHyperthyroidism in childhood: causes,when and how to treat.

J Clin ResPediatr

2013 5 Suppl 50-6

Watt T, Cramon P,Bjorner JB,Bonnema SJ, Feldt-Rasmussen U,Gluud C, Gram J,Hansen JL, HegedusL, Knudsen N,

Selenium supplementation for patientswith Graves' hyperthyroidism (theGRASS trial): study protocol for arandomized controlled trial.

Trials 2013 14 119

Czarnywojtek A,Wolinski K, Wasko R,Florek E,Zgorzalewicz-Stachowiak M,

Amiodarone-induced thyrotoxicosis in acase of Eisenmenger's syndrome.


2013 34(8) 767-72

Wang YJ, He[Clinical analysis of 403 cases of thyroidassociated ophthalmopathy].

Zhonghua YanKe Za Zhi

2013 49(8) 685-90

Regelmann MO,Sullivan CK,

Thyroid "vise" in an infant with neonatalGraves' disease.

Pediatrics 2013 132(4) e1048-51

Keklik M, Kaynar L,Yilmaz M, Sivgin S,Solmaz M, Pala C,Aribas S, Akyol G,

The results of therapeutic plasmaexchange in patients with severehyperthyroidism: a retrospectivemulticenter study.

Transfus ApherSci

2013 48(3) 327-30

Gaberscek S, BajukV, Zaletel K, Pirnat

Beneficial effects of adequate iodinesupply on characteristics of thyroid


2013 79(6) 867-73

Stan MN, Durski JM,Brito JP, Bhagra S,Thapa P, Bahn

Cohort study on radioactive iodine-induced hypothyroidism: implications forGraves' ophthalmopathy and optimal

Thyroid 2013 23(5) 620-5

Bjorgaas MR,Farstad H,Christiansen SC,

Impact of thyrotropin receptor antibodylevels on fetal development in twosuccessive pregnancies in a woman with

Horm ResPaediatr

2013 79(1) 39-43

Melcescu E, HortonWB, Pitman KT,

Euthyroid Graves' orbitopathy andincidental papillary thyroid

Hormones(Athens)

2013 12(2) 298-304

Fan W, Tandon P,Krishnamurthy

Oscillating hypothyroidism andhyperthyroidism - a case-based review.

J CommunityHosp Intern Med

2014 4(5) 25734

Marino M, Latrofa F,Menconi F, Chiovato

An update on the medical treatment ofGraves' hyperthyroidism.

J EndocrinolInvest

2014 37(11) 1041-8

Vaidya B, Pearce Diagnosis and management of BMJ 2014 349 g5128Laurberg P,Krejbjerg A,

Relapse following antithyroid drugtherapy for Graves' hyperthyroidism.

Curr OpinEndocrinol

2014 21(5) 415-21

Tyer NM, Kim TY,Martinez

Review of oral cholecystographic agentsfor the management of hyperthyroidism.

Endocr Pract 2014 20(10) 1084-92

Menconi F, Diagnosis and classification of Graves' Autoimmun Rev 2014 13(4-5) 398-402Bianco AC,Anderson G, ForrestD, Galton VA,Gereben B, Kim BW,Kopp PA, Liao XH,Obregon MJ,

American Thyroid Association Guide toinvestigating thyroid hormone economyand action in rodent and cell models.

Thyroid 2014 24(1) 88-168

Chianelli M, BizzarriG, Todino V,Misischi I, BianchiniA, Graziano F,

Laser ablation and 131-iodine: a 24-month pilot study of combinedtreatment for large toxic nodular goiter.


2014 99(7) E1283-6

Chen DY, SchneiderPF, Zhang XS, LuoXY, He ZM, Chen

Changes in graves' ophthalmopathyafter radioiodine and anti-thyroid drugtreatment of Graves' disease from 2

Exp ClinEndocrinolDiabetes

2014 122(1) 1-6

Menon BK, Rao RD,Abhyankar A, RajanMG, Basu

Comparative evaluation of 24-hourthyroid 131I uptake between gammacamera-based method using medium-

J Nucl MedTechnol

2014 42(3) 194-7

Giuffrida G,Giovinazzo S, CertoR, Vicchio TM,

An uncommon case of Marine-Lenhartsyndrome.

Arq BrasEndocrinolMetabol

2014 58(4) 398-401

Ohrling H, Torring O,Yin L, Iliadou AN,Tullgren O,

Decreased birth weight, length, andhead circumference in children born bywomen years after treatment for


2014 99(9) 3217-23

Liu M, Jing D, Hu J,Yin

Predictive factors of outcomes inpersonalized radioactive iodine ((131)I)

Am J Med Sci 2014 348(4) 288-93

Vaidya B, Wright A,Shuttleworth J,Donohoe M, Warren

Block & replace regime versus titrationregime of antithyroid drugs for thetreatment of Graves' disease: a


2014 81(4) 610-3

Olah R, Hajos P, [De Quervain thyroiditis. Corner points Orv Hetil 2014 155(17) 676-80Matta A, Koppala J,Gossman

Thyrotoxic hypokalaemic periodicparalysis: a rare presentation of Graves'

BMJ Case Rep 2014 2014

Elston MS, Tu'akoiK, Meyer-RochowGY, Tamatea JA,

Pregnancy after definitive treatment forGraves' disease--does treatmentchoice influence outcome?

Aust N Z JObstetGynaecol

2014 54(4) 317-21

Yoshihara A, NohJY, Watanabe N,Iwaku K, KobayashiS, Suzuki M, Ohye

Lower incidence of postpartumthyrotoxicosis in women with Gravesdisease treated by radioiodine therapythan by subtotal thyroidectomy or with

Clin Nucl Med 2014 39(4) 326-9

Zhu CY, Zhang GX,Yu ZZ, Li ZJ, Fan

Pseudomonas aeruginosa ecthymagangrenosum in a woman with recurrent

Int J Infect Dis 2014 21 19-20

Bowlt K, Cattin I, Carbimazole-associated hypersensitivity J Small Anim 2014 55(12) 643-7

Gruszka A, ZielinskiGM, Kunert-Radek

Preoperative long-acting octreotidetreatment for invasive thyrotropin-secreting pituitary macroadenoma after

J Clin Neurosci 2014 21(2) 340-2

Sioka C, SkarulisMC, Tulloch-Reid

"Hidden" bone metastasis from thyroidcarcinoma: a clinical note.

Rev Esp MedNucl Imagen Mol

2014 33(1) 36-8

Burch HB, Cooper Management of Graves Disease: A JAMA 2015 314(23) 2544-54Jiskra [Management of hypothyroidism and Vnitr Lek 2015 61(10) 868-72Maiga I, Valdes-Socin H, Thiry A,

[Alpha interferon inducedhyperthyroidism: a case report and

Rev Med Liege 2015 70(7-8) 390-4

Yang J, Zhang J, XuQ, Sheng GP, WengWW, Dong

Unusual Synchronous Methimazole-Induced Agranulocytosis and SevereHepatotoxicity in Patient with

Int J Endocrinol 2015 2015 934726

Srinivasan S, Misra Hyperthyroidism in children. Pediatr Rev 2015 36(6) 239-48

Shin T, GuerreroCalcium maelstrom: recalcitranthypocalcaemia following rapid correction


Menconi F, Leo M,Vitti P, Marcocci C,

Total thyroid ablation in Graves'orbitopathy.

J EndocrinolInvest

2015 38(8) 809-15

Liu B, Tian R, PengW, He Y, Huang R,

Radiation Safety Precautions in (131)ITherapy of Graves' Disease Based on

J ClinEndocrinol

2015 100(8) 2934-41

Kyrilli A, Tang BN,Huyge V, Blocklet D,Goldman S,

Thiamazole Pretreatment Lowers the(131)I Activity Needed to CureHyperthyroidism in Patients With


2015 100(6) 2261-7

Jacob JJ, StephenC, Paul TV, ThomasN, Oommen R,

No impact of dietary iodine restriction inshort term development ofhypothyroidism following fixed dose

Indian JEndocrinolMetab

2015 19(1) 60-5

Saki H, Cengiz A,Yurekli

Effectiveness of Radioiodine Treatmentfor Toxic Nodular Goiter.

Mol ImagingRadionucl Ther

2015 24(3) 100-4

Korte AK, Derde L,van Wijk J, Tjan

Sudden cardiac arrest as a presentationof Brugada syndrome unmasked by


Scott-Moncrieff JC,Heng HG, Weng HY,

Effect of a Limited Iodine Diet on IodineUptake by Thyroid Glands in

J Vet InternMed

2015 29(5) 1322-6

Merza Z, White D,Khanem

Struma Ovarii in Pregnancy: AnUncommon Cause of Hyperthyroidism.

Clin Nucl Med 2015 40(8) 687-8

Kim TK, LeeThe value of the mean peak systolicvelocity of the superior thyroidal artery

Ultrasonography 2015 34(4) 292-6

Dewji S, Bellamy M,Hertel N, Leggett R,Sherbini S, Saba M,

Estimated dose rates to members ofthe public from external exposure topatients with 131I thyroid treatment.

Med Phys 2015 42(4) 1851-7

Liu X, Liu J, Fan L,Shi

Erythrocytosis associated withhyperthyroidism: a rare case report and

Endocr Res 2015 40(4) 177-80

Stathopoulos P,Gangidi S, Kotrotsos

Graves' disease: a review of surgicalindications, management, and

Int J OralMaxillofac Surg

2015 44(6) 713-7

Sfiligoj D,Gaberscek S,

Factors influencing the success ofradioiodine therapy in patients with

Nucl MedCommun

2015 36(6) 560-5

Xie LJ, Zhou HJ, LiJF, Zhang F, ZengFW, Qin LP, Chen Y,

Redistribution of body composition inpatients with Graves' disease afteriodine-131 treatment.

Eur J Clin Nutr 2015 69(7) 856-61

Kelley Endocrinology Update: Thyroid FP Essent 2016 451 11-16Smith TJ, Hegedus Graves' Disease. N Engl J Med 2016 375(16) 1552-1565Bartalena L,Chiovato L, Vitti

Management of hyperthyroidism due toGraves' disease: frequently asked

J EndocrinolInvest

2016 39(10) 1105-14

De Leo S, Lee SY, Hyperthyroidism. Lancet 2016 388(100906-918Prunty JJ, Heise Graves' Disease Pharmacotherapy in Pharmacotherap 2016 36(1) 64-83Canto AU,Dominguez PN,

Comparison of Fixed versus CalculatedActivity of Radioiodine for the

EndocrinolMetab (Seoul)

2016 31(1) 168-73

Mojsak MN,Abdelrazek S,Szumowski P,Rogowski F, SykalaM, Kostecki J,

Single, very low dose (0.03 mg) ofrecombinant human thyrotropin (rhTSH)effectively increases radioiodine uptakein the I-131 treatment of large nontoxicmultinodular goiter.


2016 19(1) 3-11

Taieb D, BournaudC, Eberle MC,Catargi B, SchvartzC, Cavarec MB,Faugeron I, ToubertME, Benisvy D,

Quality of life, clinical outcomes andsafety of early prophylacticlevothyroxine administration in patientswith Graves' hyperthyroidismundergoing radioiodine therapy: arandomized controlled study.

Eur J Endocrinol 2016 174(4) 491-502

Korkusuz H, HappelC, Koch DA,Gruenwald

Combination of Ultrasound-GuidedPercutaneous Microwave Ablation andRadioiodine Therapy in Benign Thyroid

Rofo 2016 188(1) 60-8

Ding Y, Xing J, FangY, Wang Y, Zhang Y,

131I therapy for 345 patients withrefractory severe hyperthyroidism:

Exp Biol Med(Maywood)

2016 241(3) 290-5

Radacic-Aumiler M,Kraljickovic I,Edeljic-Turk V,

No Adverse Effects After RadioiodineTreatment at 3 Weeks of Pregnancy.

Clin Nucl Med 2016 41(12) 964-965

Gill G, Bajwa H,Strouhal P, Buch

Interaction of interferon alpha therapywith thyroid function tests in the

J Med Case Rep 2016 10(1) 253

Cui W, Deng B,Wang W, Liu

Graves' hyperthyroidism accompaniedwith acute hepatitis B virus infection: an

Virol J 2016 13 80

Guan L, Chen G,Zhang J, Wang

The preliminary clinical observation andanalysis of childbearingage women with

Biosci Trends 2016 10(4) 307-14

Cunha FM,Rodrigues E,Oliveira J, Saavedra

Graves' disease in a mediastinal masspresenting after total thyroidectomy fornontoxic multinodular goiter: a case

J Med Case Rep 2016 10 70

Li L, Sun L, Yu S,Ma

Increased pertechnetate and radioiodineuptake in the thyroid gland with

Hell J Nucl Med 2016 19(1) 49-52

Sheehan MT, DoiTransient Hypothyroidism afterRadioiodine for Graves' Disease:

Clin Med Res 2016 14(1) 40-5

Bettencourt A,Daniel GB, PancieraD, Larson M, Werre

EVALUATION OF THYROID TOBACKGROUND RATIOS ANDCOMPARISON OF VARIOUSSCINTIGRAPHIC MEASUREMENTS

Vet RadiolUltrasound

2016 57(3) 290-8

Subramanian M,Baby MK, Seshadri

The effect of prior antithyroid drug useon delaying remission in high uptake

Endocr Connect 2016 5(1) 34-40

Gietka-CzernelThe thyroid gland in postmenopausalwomen: physiology and diseases.

PrzMenopauzalny

2017 16(2) 33-37

Bucci I, Giuliani C,Napolitano

Thyroid-Stimulating Hormone ReceptorAntibodies in Pregnancy: Clinical

Front Endocrinol(Lausanne)

2017 8 137

Al Eyadeh AA, Al-Sarihin KM, EtewiSM, Al-Omari AA,

Thyroid cancer post radioactive iodinetreatment for hyperthyroidism (caseseries and review of the literature).

Endokrynol Pol 2017

Liu J, Fu J, Xu Y,Wang

Antithyroid Drug Therapy for Graves'Disease and Implications for

Int J Endocrinol 2017 2017 3813540

HesarghattaShyamasunder A,

Measuring TSH receptor antibody toinfluence treatment choices in Graves'


2017 86(5) 652-657

Carle A, AndersenSL, Boelaert K,

MANAGEMENT OF ENDOCRINEDISEASE: Subclinical thyrotoxicosis:

Eur J Endocrinol 2017 176(6) R325-R337

Mellington FE,Dayan CM,Dickinson AJ,Hickey JL,MacEwen CJ,McLaren J, Perros

Management of thyroid eye disease inthe United Kingdom: A multi-centrethyroid eye disease audit.

Orbit 2017 36(3) 159-169

Ballal S,Soundararajan R,Bal

Re-establishment of normal radioactiveiodine uptake reference range in the eraof universal salt iodization in the Indian

Indian J MedRes

2017 145(3) 358-364

Binh DD, NakajimaT, Otake H, HiguchiT, Tsushima

Iodine concentration calculated by dual-energy computed tomography (DECT)as a functional parameter to evaluate

BMC MedImaging

2017 17(1) 43

Wang R, Tan J,Zhang G, Zheng W,

Risk factors of hepatic dysfunction inpatients with Graves' hyperthyroidism

Medicine(Baltimore)

2017 96(5) e6035

Sundaresh V, BritoJP, Thapa P, Bahn

Comparative Effectiveness ofTreatment Choices for Graves'

Thyroid 2017 27(4) 497-505

Azorin Belda MJ,Martinez CaballeroA, Figueroa ArdilaGC, MartinezRamirez M, Gomez

Recombinant human thyrotropinstimulation prior to 131I therapy in toxicmultinodular goitre with low radioactiveiodine uptake.

Rev Esp MedNucl Imagen Mol

2017 36(1) 7-12

cussion 229

z 2p following 64

Authors Title Journal Year Volume Pages 2000 1(1-2) 19-25 2000 … › common › CQ6_PubMed.pdf ·...

Documents

Transcript of Authors Title Journal Year Volume Pages 2000 1(1-2) 19-25 2000 … › common › CQ6_PubMed.pdf ·...